GSK Can't Sink Avandia Prescription Coverage RICO Suits

By Andrew Scurria · October 24, 2013, 1:57 PM EDT

GlaxoSmithKline LLC failed Wednesday to escape a trio of racketeering class actions in Pennsylvania federal court alleging its concealment of heart risks associated with the diabetes drug Avandia conned health benefit...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

Case Number

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Date Filed

October 18, 2007

Recent Articles By Andrew

March 18, 2015
Social Services Provider FEGS To Close Up Shop In Ch. 11
February 27, 2015
Bad Buys Drive Houston Health System Into Bankruptcy
January 02, 2015
Fla. Nursing Home's Bold Ch. 11 Play Pays Off
December 22, 2014
Fla. Nursing Home's Bold Ch. 11 Play Stays Unresolved
December 05, 2014
American Laser Skincare Shuts Clinics, Files For Ch. 7
November 19, 2014
Dangers Lurk For Investors In Health Care Turnarounds
November 05, 2014
Nursing Home's Ch. 11 Threatens Agency Police Powers
July 28, 2014
McGuireWoods Beats Hospital's Suit Over Suspect LBO
July 15, 2014
M*Modal To Emerge From Ch. 11 With $350M Less Debt
July 10, 2014
DLA Piper Can't Duck Hospital's Claims About Dodgy LBO